3,4-Methylenedioxybenzaldehyde



Compound IDCDAMM00799
Common name3,4-Methylenedioxybenzaldehyde
IUPAC name1,3-benzodioxole-5-carbaldehyde
Molecular formulaC8H6O3

Experimental data

Retention time12.6
Adduct[M+H]+
Actual mz151.041
Theoretical mz151.039
Error12.08
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.5573

Identifiers and class information

Inchi keySATCULPHIDQDRE-UHFFFAOYSA-N
SmilesO=CC1=CC=C2OCOC2=C1
SuperclassOrganoheterocyclic compounds
ClassBenzodioxoles

Pharmacokinetic properties

Number of descriptor values(#stars)4
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)1
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)150.134
Computed dipole moment(dipole)3.634
Total solvent accessible surface area (SASA)304.143
Hydrophobic component of SASA (FOSA)90.191
Hydrophilic component of SASA (FISA)77.262
Pie component of the SASA (PISA)136.689
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)482.531
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)3.5
Free energy of solvation of dipole (dip^2/V)0.0273686
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.978221
Predicted polarizability in cubic angstroms (QPpolrz)13.82
Predicted hexadecane/gas partition coefficient (QPlogPC16)4.859
Predicted octanol/gas partition coefficient (QPlogPoct)6.194
Predicted water/gas partition coefficient (QPlogPw)5.133
Predicted octanol/water partition coefficient (QPlogPo/w)0.486
Predicted aqueous solubility (QPlogS)-0.122
Conformation-independent predicted aqueous solubility (CIQPlogS)-1.112
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-2.536
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1833.24
Predicted brain/blood partition coefficient (QPlogBB)-0.035
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)952.49
Predicted skin permeability, log Kp (QPlogKp)-2.366
PM3 calculated ionization potential (IP(ev))9.299
PM3 calculated electron affinity (EA(eV))0.673
Number of likely metabolic reactions (#metab)0
Prediction of binding to human serum albumin (QPlogKhsa)-0.96
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)88.195
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)55.894
Number of nitrogen and oxygen atoms (#NandO)3
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P27338MAOBMonoamine oxidase BT83011SEA
P11509CYP2A6Cytochrome P450 2A6T06455SEA
P11309PIM1Serine/threonine-protein kinase PIM1T50594SEA
Q15078CDK5R1Cyclin-dependent kinase 5/CDK5 activator 1T09513SEA
Q9Y463DYRK1BDual specificity tyrosine-phosphorylation-regulated kinase 1BT82720SEA
P25101EDNRAEndothelin receptor ET-AT23499SEA
Q00535CDK5Cyclin-dependent kinase 5/CDK5 activator 1T20973SEA
P49761CLK3Dual specificity protein kinase CLK3T21585SEA
P17936IGFBP3Insulin-like growth factor binding protein 3T33455SEA
Q92630DYRK2Dual-specificity tyrosine-phosphorylation regulated kinase 2T39486SEA
P51843NR0B1Orphan nuclear receptor DAX-1T23191SEA
Q7RTX1TAS1R1Taste receptorT41263SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83011DI0115Dementia[ICD-11: 6D80-6D8Z]P27338MAOB
T83011DI0117Depression[ICD-11: 6A70-6A7Z]P27338MAOB
T83011DI0190Hypertension[ICD-11: BA00-BA04]P27338MAOB
T83011DI0243Malaria[ICD-11: 1F40-1F45]P27338MAOB
T83011DI0264Migraine[ICD-11: 8A80]P27338MAOB
T83011DI0331Parkinsonism[ICD-11: 8A00]P27338MAOB
T06455DI0283Mycosis fungoides[ICD-11: 2B01]P11509CYP2A6
T06455DI0351Psoriasis[ICD-11: EA90]P11509CYP2A6
T50594DI0012Acute myeloid leukaemia[ICD-11: 2A60]P11309PIM1
T50594DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P11309PIM1
T23499DI0070Cardiovascular disease[ICD-11: BA00-BE2Z]P25101EDNRA
T23499DI0356Pulmonary hypertension[ICD-11: BB01]P25101EDNRA
T23499DI0425Urinary system clinical symptom[ICD-11: MF8Y]P25101EDNRA
T20973DI0308Obesity[ICD-11: 5B80-5B81]Q00535CDK5
T33455DI0115Dementia[ICD-11: 6D80-6D8Z]P17936IGFBP3
T41263DI0078Cholera[ICD-11: 1A00]Q7RTX1TAS1R1

Copyright © 2025